Simons et al. 1996, “What dose of vitamin E is required to reduce suseptibility of LDL to oxidation?”, Australian and New Zealand Journal of Medicine, vol 26 no 4, p. 496-503.* |
Christien et al. 1997, “gamma-tocopherol traps mutagenic electrophiles . . . ”, Proceedings of the National Academy of Sciences, vol 94, p. 3217-3222.* |
Schultz et al. 1995, “Novel urinary metabolite of alpha-tocopherol . . . ”, American Journal of Clinical Nutrition, vol 62 supp 6, p. 1527S-1534S.* |
Darko et al. 1997, “Endogenous Natriuretic Factors 6: The Stereochemistry of a Natriuretic gamma-tocopherol Metabolite LLU-alpha”, vol 282 no 2, p. 648-656.* |
HerbiesNaturals [online], [retrieved on Nov. 15, 2001]. Retrieved from the internet: <URL: http;//www.herbiesnaturals.com/search/show.php3?id=1168>, p. 1.* |
US Trademark 2169587 [online], [retrieved on Nov. 14, 2001]. Retrieved from the internet:<URL: http://tess.uspto.gov/bin/gatexexe?f=doc&state=imfbnv.2.12, p. 1.* |
Saldeen et al., J. of Amer. Coll. of Cardiology, vol. 34, No. 4, pp. 1208-1215, (1999). |
Porkkala-Sarataho et al., Arterioscler Thromb. Vasc. Biol., vol. 20, No. 9, pp. 2087-2093, (2000). |
Suarna et al., Biochimica Et. Biophysica Acta., vol. 1166, No. 2-3, pp. 163-170, (1993). |
Jiang et al., PNAS, vol. 97, No. 21, pp. 11494-11499, (2000). |
Stahl et al., Anal. Biochem., vol. 275, pp. 254-259, (1999). |